News Agency
Men's Weekly

Jacobio's KRAS G12C Inhibitor JAB-21822 was Granted Breakthrough Therapy Designations by China CDE

  • Written by PR Newswire
Jacobio's KRAS G12C Inhibitor JAB-21822 was Granted Breakthrough Therapy Designations by China CDE

BEIJING, SHANGHAI and BOSTON, Dec. 16, 2022 /PRNewswire/ -- Jacobio Pharma (1167. HK) announced that the Company's in-house KRAS G12C inhibitor JAB-21822 was granted breakthrough therapy designations for the second line and above treatment of advanced or metastatic non-small cell lung cancer (NSCLC) patients with KRAS G12C mutation...

Read more: Jacobio's KRAS G12C Inhibitor JAB-21822 was Granted Breakthrough Therapy Designations by China CDE

Contactless Payments and the Rise of the Smart EFTPOS Machine

Introduction In the fast-evolving world of digital commerce, the way consumers pay for goods and services has undergone a dramatic transformation. Traditional cash registers are being replaced with sleek, intelligent systems capable of handling payments quickly and securely. Among these innovations... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion